The neuroaftive peptides SCPB (small cardioactive peptide B) and FMRFamide (Phe-Met-Arg-Phe-NH2), both originally isolated from molluscs, have potent modulatory effects upon the production of patterned motor activity in identified neurons (e.g., B5 and B19) in the buccal ganglia of the snail Helisoma. Such patterned motor activity has previously been shown to underlie feeding behavior. (7, 8) .
Micromolar concentrations of SCPB initiate patterned motor activity in quiescent ganglia and increase the rate of activity in ganglia that are spontaneously active. Micromolar concentrations of FMRFamide inhibit patterned motor activity in Helisoma buccal ganglia, and 10 FLM FMRFamjde completely suppresses such activity. In addition, there are both anti-SCPBand anti-FMRFamide-immunoreactive neurons in Helisoma buccal ganglia. Our results suggest that peptides may play a prominent role in the regulation of feeding behavior in Helisoma.
Neuroactive peptides appear to be ubiquitous. Immunocytochemical staining, for example, has revealed "peptidergic neurons" throughout the metazoa. In addition, neuromodulatory effects of peptides have been implicated in a variety of systems (1) (2) (3) . However, there are relatively few systems in which peptidergic regulation of a discrete behavior appears amenable to physiological and anatomical analyses at the level of identified neurons. Certain invertebri systems (4) (5) (6) , and especially neuronal systems controlling feeding in gastropod molluscs, may allow such analyses (7, 8) .
Several aspects of the neural basis of feeding in the snail Helisoma trivolvis have been described. Cyclical activity of many identified effector neurons and elements of the central pattern generator has been characterized (9) (10) (11) . In addition, the monoamines serotonin (12) and dopamine (13) have been shown to activate or modulate such patterned motor activity (PMA) associated with feeding and generated by neurons in the buccal ganglia. As a first step in characterizing the potential roles of neuroactive peptides in regulating feeding behavior in Helisoma, we report here that two neuroactive peptides, originally discovered in molluscs, have profound effects on the production of PMA (which apparently represents "fictive feeding") by buccal ganglion neurons. Small cardioactive peptide B (SCPB, Met-Asn-Tyr-Leu-Ala-PhePro-Arg-Met-NH2; ref. 14) has stimulatory effects upon the generation of PMA that resemble, at least superficially, those described for serotonin (5-hydroxytryptamine) and dopamine. In contrast, FMRFamide (Phe-Met-Arg-Phe-NH2; ref. 15) inhibits and, at a sufficient concentration (10-5 M), effectively suppresses PMA in the buccal ganglia. SCP has been indicated, by chromatographic techniques, to occur in Helisoma central nervous system (see table 1 in ref. 14) . We show here that the buccal ganglion ofHelisoma contains both neurons with SCPB-like immunoreactivity and neurons with anti-FMRFamide immunoreactivity.
MATERIALS AND METHODS Albino specimens of Helisoma trivolvis were used; they were obtained from stocks maintained in the laboratory of A. G. M. Bulloch (University of Calgary) and derived from the Oregon Red stock of S. B. Kater's laboratory (University of Iowa). The dissection, the physiological saline, and the electrophysiological recording and display techniques have been described (16, 17) . For these experiments, either isolated buccal ganglia or buccal ganglia attached to the central ring of ganglia via the cerebrobuccal connectives were used. There was no detectable difference in the effects of peptides upon PMA whether or not the central ganglia were attached, but the rate of spontaneous PMA varies considerably and tends to be higher in isolated buccal ganglia. Once it had been determined that SCPB was excitatory and FMRFamide was inhibitory, relatively quiescent preparations were used for SCPB experiments and relatively active preparations were used for FMRFamide experiments. The synthetic peptides, SCPB (Peninsula Laboratories, San Carlos, CA) and FMRFamide (Sigma), were used. Saline volume (<0.5 ml) in the recording chamber was maintained by suction from the surface, and solutions were changed by perfusing 4-10 ml of normal physiological saline or peptide solutions through the chamber.
PMA was monitored by intracellular recordings from identified neuron B5, which innervates the gut (18) , and/or B19, a supralateral radular tensor muscle motoneuron (9) . These neurons are the preferred monitors of PMA because they are two of the largest neurons in the buccal ganglia and they show distinctive electrophysiological activity throughout each feeding rasp or cycle of PMA. They generate bursts of action potentials during the protraction phase of the cycle (9, 19) and, during the retraction phase (when retractor motoneurons generate bursts of action potentials), neurons B5 and B19 receive a large, compound, inhibitory postsynaptic potential (IPSP). When the central pattern generator is sporadically active or cycling at a low rate, the frequency of action potentials in the retractor motoneuron bursts can be variable, and action potentials may occur during the interburst interval. Under these conditions the delineation of retractor bursts can be somewhat problematical. In contrast, even when "feeding cycles" occur at low rates, the large IPSPs of neurons B5 and B19 remain distinctive, reflecting the rate of activity in the central pattern generator.
The effects of peptides upon PMA were quantified by counting the number of these large IPSPs occurring during three defined intervals: immediately before and after appliAbbreviations: FMRFamide, Phe-Met-Arg-Phe-NH2; IPSP, inhibitory postsynaptic potential; PMA, patterned motor activity; SCPB, small cardioactive peptide B.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 7141 cation of the peptide-containing saline solution and immediately after replacement of the peptide solution with normal saline. For each experiment, the number of large IPSPs in normal saline was taken as the control value for cycles of PMA. Since the control rate of spontaneous PMA was variable, the data were normalized by calculating the percentage of the control value for the intervals in peptide solution and after wash with normal saline. The percentage of control for each of these intervals in all of the experiments was then averaged, and the average percentage of control was plotted. The intervals used in FMRFamide experiments were 1 min. However, there were often no spontaneous cycles of PMA in the minute prior to SCPB application (relatively quiescent preparations). Therefore, 3-min intervals were used for the SCPB experiments, so that the percentage of control values could be calculated. The significance of the peptidergic effects was confirmed by a onetailed t test.
For immunocytochemical staining, ganglia, connectives, and nerves were dissected in saline and pinned onto Sylgard in small Petri dishes. They were treated for up to 30 min (depending upon the size of the donor animal) at 20'C with 0.5-1.0o protease (Sigma type VI) in saline, rinsed briefly in saline, and fixed overnight at 4-80C in buffered picrate/paraformaldehyde (20) . They were washed 3-5 times (1 hr each) in saline at 20'C and then peptides were localized by conventional immunofluorescence methods (21) . Adaptations for thick specimens included longer incubation times (up to 2 days at 20'C for primary antiserum) and the addition of 0.1% NaN3 to the primary antiserum to prevent growth of protease-generating microorganisms (31) . The best staining of neuronal somata was obtained in ganglia from small animals (4-mm vertical shell diameter) treated with protease for 5-10 min. We used a rabbit polyclonal antiserum anti-mouse IgG. Characterization of the antiserum to FMRFamide used in this study showed it to be highly specific for the COOH-terminal amino acid sequence, -Arg-Phe-NH2 (22) . A characterization of the monoclonal antibody to SCPB used in this study is forthcoming (B. Masinovsky, S. Kempf, J. Calloway, and A. 0. D. Willows; personal communication). Specificity in Helisoma was monitored by staining with antisera preabsorbed overnight at 4-80C with 10-4-10-6 M synthetic peptide. RESULTS SCPB and FMRFamide have antagonistic effects upon the production of PMA in buccal ganglion neurons. The inhibitory effects of FMRFamide and the excitatory effects of SCPB upon PMA are exemplified in Fig. 1 . In the case shown, 10-6 M FMRFamide completely suppressed cyclical PMA and, in addition, caused a large hyperpolarization of neuron B5. However, the concentration of FMRFamide required to suppress PMA varied for ganglia from different animals. In some ganglia PMA was inhibited relatively weakly by 10-6 M but was totally suppressed by 10-5 M FMRFamide. The effects of 10-6 M and 10-5 M FMRFamide were quantified as indicated in Methods. FMRFamide at 10-6 M reduced the cyclical PMA rate to one-third of the control rate (mean ± SEM = 33.8 ± 7.3%, n = 21; P < 0.001; Fig. 2A ). Upon washing with normal saline, the PMA rate returned to normal. The higher concentration of FMRFamide (10-5 M) completely suppressed PMA (Fig. 2B , average percentage of control rate = 1.2% + 1.2%; n = 11; P < 0.001). In one experiment, two cycles of PMA occurred after the addition of 10-5 M FMRFamide. In 10 of the 11 experiments, no PMA was seen in the interval following application of 10-5 M FMRFamide. PMA again returned to control levels upon return to normal saline. Thus, FMRFamide dramatically and reversibly inhibits PMA in Helisoma buccal ganglia.
The effects of SCPB on PMA closely parallel those of 5-hydroxytryptamine (12) . SCPB (10-6 M) consistently initiated PMA in quiescent buccal ganglia (Fig. 3) 4 . The effect of SCPB on the rate of cyclical PMA. Application of 10-6 M SCPB increased the PMA rate to 1047.9% ± 404.9% of control values (n = 8 experiments in 7 animals). Threeminute intervals were used for PMA measurements and the PMA rate remained elevated during the recovery (Rec) interval immediately following removal of SCPB (average % of control rate = 527% + 300.5%, n = 8 experiments in 7 animals).
There was some residual stimulatory effect upon SCPBinduced PMA after return to normal saline. This effect is also reminiscent of the slight lag between removal of bath-applied 5-hydroxytryptamine and cessation of PMA (12) .
The similarity of the effects of SCPB and 5-hydroxytryptamine upon PMA might suggest that one of these agents acts by stimulating the release of the other. Since the serotonergic input to the buccal ganglia is known to arise from the identified cerebral neuron C1 (12, 24, 25), we were able to obtain a partial answer to this question. SCPB can activate PMA monitored in neuron B19 while having no effect upon the spiking activity of neuron C1 (Fig. 3) . Thus, 5- hydroxytryptamine may yet act by stimulating SCPB-containing neurons, but SCPB can surely activate PMA without stimulating the serotonergic system.
If the pharmacological results are to have physiological significance, there must be neuronal somata and/or processes containing FMRFamide and SCPB (or closely related peptides) in the buccal ganglia. For a first indication of their presence, we performed indirect immunofluorescence staining of buccal ganglia with antibodies to FMRFamide and SCPB. On the ventral surface of each of the paired buccal ganglia there is a single neuron with FMRFamide-like immunoreactivity that stains very brightly, and usually 2-4 other somata that are less immunoreactive (Fig. 5) . On the dorsal surface there is a large medial cluster of about 30 small neurons with FMRFamide-like immunoreactivity, several of which lie between identified neurons B5 and B19 (Fig. 5) . There are usually 7 or 8 pairs of neurons showing SCPB-like immunoreactivity on the dorsal surfaces and an additional 4 or 5 pairs on the ventral surfaces of the buccal ganglia (Fig.  6) in the "decision to feed") in Helisoma. 5-Hydroxytryptamine has diverse effects related to feeding in a variety of gastropods (27) , and there are preliminary reports that dopamine (28) and SCPB (7) can stimulate PMA in other gastropods.
The precise physiological roles of these neuroactive substances in the decision to feed in Helisoma remain unclear. For instance, tonic activity in the serotonergic neuron C1 usually activates PMA underlying feeding, but it does not always do so (12, 25) and, as shown here, action potentials in neuron C1 are unnecessary for SCPB-evoked PMA expression. Thus, activation of the serotonergic system is neither always necessary nor always sufficient for initiating PMA in the buccal ganglia, and its role in particular behavioral and environmental contexts is uncertain. Similarly, the physiological roles of FMRFamide and SCPB (or related peptides) and of dopamine in the regulation of feeding remain to be defined. Important considerations include (i) the extent to which the PMA evoked by 5-hydroxytryptamine, dopamine, and SCPB may vary qualitatively and (it) the possibility that these neuroactive substances may evoke slightly different forms ofingestive behavior (9) or even egestive behavior (29 
